查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1650481

2025 年吸入麻醉全球市場報告

Inhalation Anesthesia Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年吸入麻醉市場規模將強勁成長。到 2029 年，這一數字將成長至 23.4 億美元，複合年成長率為 9.1%。預測期內的成長歸因於對微創手術的需求增加、全球醫療保健支出的增加、新興市場外科手術數量的增加、獸醫學中吸入麻醉的採用以及政府對創新吸入麻醉劑研發的資金增加。預測期內的關鍵趨勢包括麻醉輸送系統的技術創新、兒科吸入麻醉設備的開發、向SEVOFLURANE和DESFLURANE的轉變、對環境友善麻醉劑的關注以及麻醉輸送中監測技術的整合。

預測期內老年人口的預期成長將推動吸入麻醉市場的發展。老齡人口的增加促進了吸入麻醉市場的擴大。這群人更容易患上退化性疾病疾病和慢性疾病，導致對手術和治療性介入的需求增加。老年人口的不斷增加對市場成長起到了關鍵作用，他們容易患心血管、神經、呼吸和退化性疾病等疾病。由於血管穿刺和患者依從性等問題，對老年患者經由靜脈途徑麻醉可能會不方便。例如，截至 2022 年 10 月，世界衛生組織 (WHO) 報告稱，預計到 2022 年，全球 60 歲及以上人口將從 2020 年的 10 億增加到 14 億。此外，預計到2030年，全球六分之一的人口將超過60歲。因此，預計老年人口的成長將在整個預測期內推動對吸入麻醉劑的需求。

由於慢性病的增加，吸入麻醉市場預計將成長。慢性病的特徵是持續超過三個月，需要手術介入診斷、治療和管理。吸入麻醉對於在這些手術過程中提供患者的舒適和安全至關重要。根據美國國家醫學圖書館2023年1月發布的報告，預計到2050年，患有一種或多種慢性病的50歲及以上人口數量將增加99.5%，從2020年的7152.2萬人增加到1.4266億人。因此，慢性病的增加預計將推動吸入麻醉市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球吸入麻醉市場的 PESTEL 分析（政治、社會、技術、環境、法律、促進因素、限制因素）
  • 最終用途產業分析
  • 全球吸入麻醉市場成長率分析
  • 全球吸入麻醉市場表現：規模與成長，2019 年至 2024 年
  • 全球吸入麻醉市場預測：規模與成長，2024-2029 年，2034 年
  • 全球吸入麻醉總目標市場 (TAM)

第6章 市場細分

  • 全球吸入麻醉市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • SEVOFLURANE
  • DESFLURANE
  • Isoflurane
  • 氧化亞氮
  • 全球吸入麻醉市場的應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 麻醉誘導
  • 維護
  • 全球吸入麻醉市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 全球吸入麻醉市場：SEVOFLURANE按類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 液體
  • 氣體形式
  • 全球吸入麻醉市場：DESFLURANE按類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 液體
  • 氣體形式
  • 全球吸入麻醉市場：Isoflurane細分類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 液體
  • 氣體形式
  • 全球吸入麻醉市場：氧化亞氮細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫用氧化亞氮
  • 工業氧化亞氮

第7章 區域和國家分析

  • 全球吸入麻醉市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球吸入麻醉市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

  • 吸入麻醉市場：競爭格局
  • 吸入麻醉市場：公司簡介
    • Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Halocarbon Products Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • B. Braun Melsungen AG
  • Lunan Pharmaceutical Group Co. Ltd.
  • Maruishi Pharmaceutical Co. Ltd.
  • Mylan NV
  • Piramal Enterprises Ltd.
  • Recipharm AB
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Wockhardt Ltd.
  • AstraZeneca PLC
  • CH Boehringer Sohn AG & Co. KG
  • Bristol-Myers Squibb Company
  • Eisai Co. Ltd.
  • GlaxoSmithKline PLC

第 32 章 全球競爭基準化分析與儀錶板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 吸入麻醉市場 2029-提供最多新機會的國家
  • 吸入麻醉市場 2029-提供最新興機會的細分市場
  • 吸入麻醉市場 2029-成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第 36 章 附錄

簡介目錄
Product Code: r21655

Inhalation anesthesia pertains to medications administered in operating rooms for the purpose of initiating and sustaining general anesthesia. Alongside other therapeutic effects, it induces varying degrees of drowsiness, ranging from mild to profound, ultimately achieving a state of general anesthesia. Inhalation anesthesia finds application in both the induction and maintenance phases of general anesthesia within the operating room.

Key products in the realm of inhalation anesthesia include sevoflurane, desflurane, isoflurane, and nitrous oxide. Isoflurane, specifically, is an inhaled general anesthetic employed for the initiation and upkeep of general anesthesia. Its action involves muscle relaxation and a reduction in pain sensitivity through the modification of tissue excitability. The uses of inhalation anesthesia encompass both the induction and maintenance phases, and the primary end-users are hospitals and ambulatory surgical centers.

The inhalation anesthesia market research report is one of a series of new reports from The Business Research Company that provides Inhalation anesthesia market statistics, including inhalation anesthesia industry global market size, regional shares, competitors with an inhalation anesthesia market share, detailed inhalation anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the inhalation anesthesia industry. This inhalation anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The inhalation anesthesia market size has grown strongly in recent years. It will grow from $1.54 billion in 2024 to $1.65 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to growing surgical procedures requiring anesthesia, increased geriatric population, development of inhalation anesthetics, expansion of ambulatory surgical centers, increasing prevalence of chronic diseases such as heart disease and cancer.

The inhalation anesthesia market size is expected to see strong growth in the next few years. It will grow to $2.34 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to rising demand for minimally invasive surgeries, growing global healthcare expenditure, increasing number of surgical procedures in emerging markets, adoption of inhalation anesthesia in veterinary medicine, increased government funds for r&d of innovative inhalation anesthetics. Major trends in the forecast period include technological innovations in anesthesia delivery systems, development of inhalation anesthesia devices for pediatric use, shift towards sevoflurane and desflurane, focus on eco-friendly anesthetic agents, integration of monitoring technologies in anesthesia delivery.

The anticipated growth in the geriatric population is set to drive the inhalation anesthesia market during the forecast period. The increasing number of elderly individuals contributes to the expansion of the inhalation anesthesia market as this demographic is more susceptible to degenerative diseases and chronic illnesses, leading to a heightened demand for surgeries and therapeutic interventions. The rise in the geriatric population, prone to ailments like cardiovascular, neurological, respiratory, and degenerative disorders, plays a significant role in boosting market growth. Administering anesthesia through an intravenous route to geriatric patients can be inconvenient due to issues with punctured blood vessels and patient compliance. For example, as of October 2022, the World Health Organization reports a projected global population of 1. 4 billion individuals aged 60 years by 2022 compared to 1 billion in 2020. Additionally, it is estimated that by 2030, one out of every six people worldwide will be aged 60 years or older. Consequently, the increasing geriatric population is expected to drive the demand for inhalation anesthesia throughout the forecast period.

The expected increase in chronic diseases is poised to fuel the growth of the inhalation anesthesia market. Chronic diseases, characterized by long-term persistence over three months or more, often necessitate surgical interventions for diagnosis, treatment, or management. Inhalation anesthesia becomes crucial in providing comfort and safety to patients during these surgical procedures. A report from the National Library of Medicine, published in January 2023, projects a 99. 5% increase in the number of individuals aged 50 years and older with one or more chronic illnesses, reaching 142. 66 million by 2050 in the United States, up from 71. 522 million in 2020. As a result, the upsurge in chronic diseases is expected to propel the growth of the inhalation anesthesia market.

In response to industry demands and to strengthen their market positions globally, numerous companies in the inhalation anesthesia sector are developing innovative products like Sedaconda. Sedaconda, an inhaled sedation therapy delivered through the Anaesthetic Conserving Device (ACD), received approval for use in intensive care. For example, in February 2022, Sedana Medical AB, a Sweden-based med-tech and pharmaceutical company, introduced Sedaconda (isoflurane) to the German market. Sedaconda (isoflurane) is administered using the medical device known as Sedaconda ACD (Anaesthetic Conserving Device) and is the sole approved inhaled sedation therapy authorized for use in intensive care settings.

Leading companies in the inhalation anesthesia market are channeling their efforts into developing innovative products such as end-tidal (ET) control software to enhance their offerings. The End-tidal (Et) Control software, designed for administering general anesthesia through the Aisys CS2 Anesthesia Delivery System, received FDA pre-market approval (PMA) from GE Healthcare Technologies Inc., a US-based medical technology company, in April 2022. This software facilitates semi-automated anesthesia administration by enabling anesthesia providers to set and maintain end-tidal oxygen and anesthetic agent targets, improving precision in inhalation anesthesia delivery, streamlining workflows, reducing drug wastage, and contributing to cost savings and reduced greenhouse gas emissions in healthcare settings.

In January 2022, Dechra Pharmaceuticals, a UK-based specialist veterinary pharmaceuticals and related products business, acquired Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic from Halocarbon Life Sciences for an undisclosed amount. This acquisition adds Isoflurane and Sevoflurane to Dechra's pharmaceutical companion animal portfolio, focusing on areas such as endocrinology, anesthesia, fluid therapy, dermatology, ophthalmology, pain management, joint health support, and dental care. Halocarbon Life Sciences is a US-based leader in supplying isoflurane and sevoflurane inhalation anesthetic products for human and veterinary applications.

Major companies operating in the inhalation anesthesia market include Abbvie Inc., Baxter International Inc., Fresenius SE & Co. KGaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC, B. Braun Melsungen AG, Lunan Pharmaceutical Group Co. Ltd., Maruishi Pharmaceutical Co. Ltd., Mylan N. V., Piramal Enterprises Ltd., Recipharm AB, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Wockhardt Ltd., AstraZeneca PLC, C. H. Boehringer Sohn AG & Co. KG, Bristol-Myers Squibb Company, Eisai Co. Ltd., GlaxoSmithKline PLC, Johnson & Johnson Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi S. A., Takeda Pharmaceutical Company Limited, Teijin Pharma Limited, UCB S. A., Zydus Lifesciences Limited

North America was the largest region in the inhalation anesthesia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inhalation anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the inhalation anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The inhalation anesthesia market consists of sales of nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inhalation Anesthesia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inhalation anesthesia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inhalation anesthesia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inhalation anesthesia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Sevoflurane; Desflurane; Isoflurane; Nitrous Oxide
  • 2) By Application: Induction; Maintenance
  • 3) By End User: Hospitals; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Sevoflurane: Liquid Form; Gas Form
  • 2) By Desflurane: Liquid Form; Gas Form
  • 3) By Isoflurane: Liquid Form; Gas Form
  • 4) By Nitrous Oxide: Medical-Grade Nitrous Oxide; Industrial-Grade Nitrous Oxide
  • Companies Mentioned: Abbvie Inc.; Baxter International Inc.; Fresenius SE & Co. KGaA; Halocarbon Products Corporation; Hikma Pharmaceuticals PLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Inhalation Anesthesia Market Characteristics

3. Inhalation Anesthesia Market Trends And Strategies

4. Inhalation Anesthesia Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Inhalation Anesthesia Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Inhalation Anesthesia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Inhalation Anesthesia Market Growth Rate Analysis
  • 5.4. Global Inhalation Anesthesia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Inhalation Anesthesia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Inhalation Anesthesia Total Addressable Market (TAM)

6. Inhalation Anesthesia Market Segmentation

  • 6.1. Global Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
  • 6.2. Global Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Induction
  • Maintenance
  • 6.3. Global Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • 6.4. Global Inhalation Anesthesia Market, Sub-Segmentation Of Sevoflurane,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Form
  • Gas Form
  • 6.5. Global Inhalation Anesthesia Market, Sub-Segmentation Of Desflurane,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Form
  • Gas Form
  • 6.6. Global Inhalation Anesthesia Market, Sub-Segmentation Of Isoflurane,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Form
  • Gas Form
  • 6.7. Global Inhalation Anesthesia Market, Sub-Segmentation Of Nitrous Oxide,By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical-Grade Nitrous Oxide
  • Industrial-Grade Nitrous Oxide

7. Inhalation Anesthesia Market Regional And Country Analysis

  • 7.1. Global Inhalation Anesthesia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Inhalation Anesthesia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inhalation Anesthesia Market

  • 8.1. Asia-Pacific Inhalation Anesthesia Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inhalation Anesthesia Market

  • 9.1. China Inhalation Anesthesia Market Overview
  • 9.2. China Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inhalation Anesthesia Market

  • 10.1. India Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inhalation Anesthesia Market

  • 11.1. Japan Inhalation Anesthesia Market Overview
  • 11.2. Japan Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inhalation Anesthesia Market

  • 12.1. Australia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inhalation Anesthesia Market

  • 13.1. Indonesia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inhalation Anesthesia Market

  • 14.1. South Korea Inhalation Anesthesia Market Overview
  • 14.2. South Korea Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inhalation Anesthesia Market

  • 15.1. Western Europe Inhalation Anesthesia Market Overview
  • 15.2. Western Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inhalation Anesthesia Market

  • 16.1. UK Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inhalation Anesthesia Market

  • 17.1. Germany Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inhalation Anesthesia Market

  • 18.1. France Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inhalation Anesthesia Market

  • 19.1. Italy Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inhalation Anesthesia Market

  • 20.1. Spain Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inhalation Anesthesia Market

  • 21.1. Eastern Europe Inhalation Anesthesia Market Overview
  • 21.2. Eastern Europe Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inhalation Anesthesia Market

  • 22.1. Russia Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inhalation Anesthesia Market

  • 23.1. North America Inhalation Anesthesia Market Overview
  • 23.2. North America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inhalation Anesthesia Market

  • 24.1. USA Inhalation Anesthesia Market Overview
  • 24.2. USA Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inhalation Anesthesia Market

  • 25.1. Canada Inhalation Anesthesia Market Overview
  • 25.2. Canada Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inhalation Anesthesia Market

  • 26.1. South America Inhalation Anesthesia Market Overview
  • 26.2. South America Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inhalation Anesthesia Market

  • 27.1. Brazil Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inhalation Anesthesia Market

  • 28.1. Middle East Inhalation Anesthesia Market Overview
  • 28.2. Middle East Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inhalation Anesthesia Market

  • 29.1. Africa Inhalation Anesthesia Market Overview
  • 29.2. Africa Inhalation Anesthesia Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Inhalation Anesthesia Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Inhalation Anesthesia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inhalation Anesthesia Market Competitive Landscape And Company Profiles

  • 30.1. Inhalation Anesthesia Market Competitive Landscape
  • 30.2. Inhalation Anesthesia Market Company Profiles
    • 30.2.1. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Halocarbon Products Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hikma Pharmaceuticals PLC Overview, Products and Services, Strategy and Financial Analysis

31. Inhalation Anesthesia Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Lunan Pharmaceutical Group Co. Ltd.
  • 31.3. Maruishi Pharmaceutical Co. Ltd.
  • 31.4. Mylan N. V.
  • 31.5. Piramal Enterprises Ltd.
  • 31.6. Recipharm AB
  • 31.7. Sandoz International GmbH
  • 31.8. Sun Pharmaceutical Industries Ltd.
  • 31.9. Teva Pharmaceutical Industries Ltd.
  • 31.10. Wockhardt Ltd.
  • 31.11. AstraZeneca PLC
  • 31.12. C. H. Boehringer Sohn AG & Co. KG
  • 31.13. Bristol-Myers Squibb Company
  • 31.14. Eisai Co. Ltd.
  • 31.15. GlaxoSmithKline PLC

32. Global Inhalation Anesthesia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inhalation Anesthesia Market

34. Recent Developments In The Inhalation Anesthesia Market

35. Inhalation Anesthesia Market High Potential Countries, Segments and Strategies

  • 35.1 Inhalation Anesthesia Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Inhalation Anesthesia Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Inhalation Anesthesia Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer